On-Demand Webinar
Smart Pharmacovigilance - Go beyond mandatory compliance by realizing the full value of your drug safety data
In today’s regulatory environment, pharmacovigilance is non-negotiable, but are you optimizing drug safety by taking full advantage of all your data?
See how Business & Decision’s Business Intelligence and Life Science experts have utilized QlikView’s associative data model to build an application that enables users to intuitively analyze adverse reactions data, giving them powerful insight into adverse events and how they are reported to the FDA.
See Key Performance Indicators for pharmaceutical companies including:
- Serious flags
- Proportional reporting ratios
- Timeline for reporting adverse events to the FDA: how many were late and why?
Discover how you can extract maximum value from your adverse reactions data through rapid integration and intuitive analysis, allowing you to take your organization from mandatory pharmacovigilance and drug safety compliance to optimal pharmacodiligence.